Glaukos (NYSE:GKOS) announced today that it submitted a supplemental premarket approval application to the FDA for its iStent Infinite system. San Clemente, California–based Glaukos designed the iStent Infinite trabecular micro-bypass system for use in a standalone procedure to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma uncontrolled by prior surgery or medical therapy. Get […]
Implants
Bioventus triggers $50M option to acquire CartiHeal
Bioventus (NSDQ:BVS) announced today that it chose to make a $50 million escrow payment to acquire CartiHeal and its Agili-C implant. Durham, N.C.-based Bioventus elected to make its escrow payment pursuant to its option and equity purchase agreement with CartiHeal to signal its intent to move forward with an acquisition of the company. According to […]
Smith+Nephew touts analysis of Oxinium in total hip arthroplasty
Smith+Nephew (NYSE:SNN) today touted its Oxinium technology as the best performing bearing with the lowest revision risk in total hip arthroplasty. London Based S+N shared results substantiated by four national and regional joint registries over the last 20 years, covering more than 2 million procedures from which to draw, according to a news release. The […]
Zimmer Biomet, Canary Medical win FDA de novo nod for smart knee implant
Zimmer Biomet (NYSE:ZBH) and Canary Medical announced today that the FDA granted de novo classification for Persona IQ. The de novo grant and marketing authorization comes for the tibial extension for Persona IQ, which the companies tout as the first and only smart knee implant cleared by the FDA for total knee replacement surgery. (Canary […]
FDA approves MicroTransponder’s stroke rehab neurostim system
The FDA announced today that it approved the MicroTransponder Vivistim paired VNS system for chronic ischemic stroke rehabilitation. MicroTransponder designed its Vivistim System as a first-of-its-kind, drug-free rehabilitation system for treating moderate to severe upper extremity motor deficits associated with chronic ischemic stroke using vagus nerve stimulation, according to an FDA news release. Vivistim electrically […]
How Medtronic fit a battery into a tiny pacemaker
Medtronic’s Micra pacemakers are one-tenth the size of what was previously out there. How the medtech giant did it provides lessons for anyone looking to shrink an implantable device. It was an all-hands-on-deck effort that consumed Medtronic in the early 2010s: the in-house creation of a pacemaker small enough to go inside the heart via […]
DePuy Synthes launches Inhance shoulder system
Johnson & Johnson’s (NYSE:JNJ) DePuy Synthes this week announced that it has launched its Inhance shoulder system. DePuy Synthes designed the Inhance system as a fully integrated shoulder arthroplasty system. It has an intuitive stemless-first surgical approach that offers surgeons the ability to seamlessly transition from stemless to stemmed implants during surgical procedures, according to the […]
Medtronic to acquire Intersect ENT in $1.1B deal
Medtronic (NYSE:MDT) today announced that it has entered a definitive agreement to acquire Intersect ENT (NSDQ:XENT) for $1.1 billion. Medtronic will acquire all outstanding shares of the Menlo Park, Calif.-based sinus implant maker for $28.25 per share in an all-cash transaction. The deal is expected to close toward the end of Medtronic’s 2021–22 fiscal year, subject to […]
Abbott CMO Dr. Nick West touts latest iteration of drug-eluting stent
Abbott executive Dr. Nick West believes the company offers the “best-in-class” drug-eluting stent with its Xience platform. When Abbott (NYSE:ABT) CMO & divisional VP of global medical affairs for its vascular business Dr. Nick West looks back at his use of drug-eluting stents in the early 2000s, all he sees now is innovation. As a practicing interventional cardiologist, West […]
FDA clears Medtronic’s AI algorithms for cardiac monitoring
Medtronic (NYSE:MDT) announced today that the FDA cleared two of its AccuRhythm AI algorithms for use with the Linq II ICM. Fridley, Minn.–based Medtronic’s AccuRhythm AI applies artificial intelligence to heart rhythm event data collected by the Linq II insertable cardiac monitor (ICM) to improve the information provided to physicians for better diagnoses and treatments […]
Intersect ENT launches VenSure balloon sinus dilation system in U.S.
Intersect ENT (NSDQ:XENT) today announced that it has commercially launched its VenSure balloon sinus dilation system and Cube 4D navigation system in the U.S. Menlo Park, Calif.-based Intersect ENT designed the VenSure balloon and Cube 4D navigation system to be used in procedures that improve debilitating chronic rhinosinusitis (CRS) symptoms. Cube 4D has VirtuEye photo registration […]